NHS | Not What We Expected

Takeaway: New Home Sales bombed in Sept for reasons still unclear. That said, today's NHS print seems at odds with the preponderance of other data.

Our Hedgeye Housing Compendium table (below) aspires to present the state of the housing market in a visually-friendly format that takes about 30 seconds to consume.


NHS | Not What We Expected - Compendium 102615


Today’s Focus: New Home Sales for September


Well that wasn’t quite what we were expecting. 


New Home Sales declined -11.5% MoM in September and decelerated to +2% YoY – marking the lowest level of sales in 10 months and well off the +20% year-over-year pace of growth averaged YTD.  


Given the discrete pull forward in purchase demand (see 1st chart below) to close out September ahead of the impending TRID regulatory change on October 3rd, our expectation was for that bolus of demand to positively impact the September NHS and PHS figures and subsequently drag on the reported October data as the impact reversed. 

So, what happened?  In short, it’s unclear.  

What we do know is that the MBA & HMI (Builder Confidence) Surveys are telling a story antithetical to the NHS data and there are only a few roads available to reconcile the data.  


The MBA data is wrong, the NHS data is distorted, the preponderance of the pull forward occurred in the 90% of the housing market that is existing sales or some combination.  


We'll get some additional clarity alongside the release of September PHS data on Thursday. Below is some simple forensics on the NHS data along with some common sense speculation:


The preliminary Monthly New Home Sales data are derived from the Census Bureau’s Survey of Construction ( SOF) and are imputed based on the issuance of permits.  In other words, it’s a derived measure with significant standard error and not some direct count of contract signings.  Further, NHS carry the largest revision of any resi construction related series - a reality which stems from the fact that the count is based on permit issuance and many homes have a sales contract prior to a permit being issued.  Thus, if the apparent surge in late September activity occurred in the pre-permit phase, the impact would largely go un-captured by the preliminary survey calculation.  In that case, the Oct/Nov releases would likely carry positive revisions. 


In anyt case, definitely a soft print for NHS but given the regulatory noise and marked divergence from the MBA and HMI data, we’re content to wait for the PHS river card for confirming/disconfirming evidence on the underlying state of demand and any TRID related impacts.   



NHS | Not What We Expected - Purchase YoY


NHS | Not What We Expected - HMI LT


NHS | Not What We Expected - NHS Units   YoY TTM


NHS | Not What We Expected - NHS NHS vs SF Starts


NHS | Not What We Expected - NHS EHS to NHS ratio


NHS | Not What We Expected - NHS Inventory


NHS | Not What We Expected - NHS LT 





Joshua Steiner, CFA


Christian B. Drake


Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more

McCullough: ‘My 1-Minute Summary of My Institutional Meetings in NYC Yesterday’

What are even some of the smartest investors in the world missing right now?

read more

Cartoon of the Day: Political Portfolio Positioning

Leave your politics out of your portfolio.

read more

Jim Rickards Answers the Hedgeye 21

Bestselling author Jim Rickards says if he could be any animal he’d be a T-Rex. He also loves bonds and hates equities. Check out all of his answers to the Hedgeye 21.

read more

Amazon's New 'Big Idea': Ignore It At Your Own Peril

"We all see another ‘big idea’ out of Amazon (or the press making one up) just about every day," writes Retail Sector Head Brian McGough. "But whatever you do, DON’T ignore this one!"

read more